Guidelines for the Blood Transfusion
Services in the UK

Home
Skip Navigation Links.
Skip Navigation LinksGuidelines for UK Blood Services > Tables
   Print friendly version

Tables

Table 2.1List of some key inspection/licensing/accreditation/certification standards
Table III.ITotal blood volume (TBV) and extra-corporeal blood volume (ECV)
Table IV.ICitrate anticoagulants
Table 8.1Whole Blood, Leucocyte Depleted – additional tests
Table 8.2Red Cells, Leucocyte Depleted – additional tests
Table 8.3Red Cells in Additive Solution, Leucocyte Depleted – additional tests
Table 8.4Red Cells, Washed, Leucocyte Depleted – additional tests
Table 8.5Red Cells, Thawed and Washed, Leucocyte Depleted – additional tests
Table 8.6Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted – additional tests
Table 8.7Platelets, Apheresis, Leucocyte Depleted – additional tests
Table 8.8Platelets, Suspended in Platelet Additive Solution, Leucocyte Depleted – additional tests
Table 8.9Granulocytes, Apheresis – additional tests
Table 8.10Fresh Frozen Plasma, Leucocyte Depleted – additional tests
Table 8.11Fresh Frozen Plasma, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.12Cryoprecipitate, Leucocyte Depleted – additional tests
Table 8.13Plasma, Cryoprecipitate Depleted, Leucocyte Depleted – additional tests
Table 8.14Red Cells for Intrauterine Transfusion (IUT), Leucocyte Depleted – additional tests
Table 8.15Whole Blood for Exchange Transfusion, Leucocyte Depleted – additional tests
Table 8.16Red Cells for Exchange Transfusion, Leucocyte Depleted – additional tests
Table 8.17Red Cells for Neonates and Infants, Leucocyte Depleted – additional tests
Table 8.18Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted – additional tests
Table 8.19Fresh Frozen Plasma, Neonatal Use, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.20Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.21Platelets for IUT, Leucocyte Depleted – additional tests
Table 8.22Platelets for Neonatal Use, Leucocyte Depleted – additional tests
Table 8.23Red cell components
Table 8.24Platelet and granulocyte components
Table 8.25Plasma components
Table 8.26Neonatal and infant red cell components
Table 8.27Neonatal and infant platelet components
Table 8.28Neonatal and infant plasma components
Table 8.29Blood components suitable for use in intrauterine and exchange transfusion and neonates and infants under one year, specific requirements
Table 9.1Testing of novel components
Table 9.2Evaluation of new red cell components for transfusion: recommended tests
Table 9.3In vitro assessment
Table 9.4Evaluation of new platelet components for transfusion
Table 9.5Evaluation of novel plasma components
Table 9.6Generic flowchart of apheresis equipment acceptance
Table 9.7Summary of testing numbers required for evaluations and validations
Table 12.1Label colour coding
Table 12.2Grading system for serological tests
Table 12.3Requirements for conventional blood typing reagents
Table 12.4Chequerboard test format
Table 12.5Complement C3 and C4 activation
Table 13.1Minimum release criteria for blood products with antibodies of probable clinical significance
Table 13.2Test monitor red cell samples
Table 14.1Timing of pre-transfusion samples
Table 14.2Suggested maximum storage time of samples
Table 14.3Controls for manual and automated ABO and D grouping
Table 15.1Dilution of UK reference reagent
Table 15.2HLA antigens that are defined by serological typing
Table 15.3Characterization of HLA-specific antibodies
Table 16.1Current nomenclature for human neutrophil antigens and corresponding antibodies
Table 17.1Current HPA nomenclature for platelet-specific alloantigen and alloantibody specificities
Table 22.1Microbiological testing for tissue donors
Table 23.1Temperature/time relationships for banked tissues
Table 23.2Air classification system for manufacture of sterile medicinal products
Table 23.3Comparison of British, European and American classifications
Table 23.4Microbiological monitoring of controlled work areas
Table 23.5Ethylene oxide and ethylene chlorohydrin residue levels
Table 23.6Minimum donor/recipient data set to be kept
Table 24.1Requirements for the timing of testing
Table 24.2Label content adapted from FACT-JACIE
Table 24.3Label content for HPC-C adapted from NETCORD-FACT
Table 25.1Centre codes and names
Table 25.2aBlood group classifications
Table 25.2bBlood group and donation use limitations
Table 25.2cBlood group and donation use label text
Table 25.3Historic blood group classifications (only for use on 'Use in emergency only' labels)
Table 25.4Manufacturers'codes
Table 26.1Statements of product status
Table 26.2Glossary: uniform labelling of human tissue products
Table 27.1Envelope definition
Table 27.2Message protocol numbers
Table 27.3Message protocol 000001: blood component dispatch information: administrationline
Table 27.4Message protocol 000001: blood component dispatch information: dispatch line
Table 27.5Message protocol 000001: blood component dispatch information.
Field 10: Red cell phenotype field – antigen codes
Table 27.6Message protocol 000001: blood component dispatch information.
Field 14: Platelet-specific phenotype
Table 27.7Message protocol 000002: blood derivative dispatch information: administrationline
Table 27.8Message protocol 000002: blood derivative dispatch information: dispatch line
Table 27.9Message protocol 000003: reagent dispatch information: administrationline
Table 27.10Message protocol 000003: reagent dispatch information: dispatch line
Table 27.11Message protocol 000004: blood component dispatch acknowledgement: administrationline
Table 27.12Message protocol 000004: blood component dispatch acknowledgement: dispatch line
Table 27.13Message protocol 000005: blood component fate information: data line
Table 27.14Message protocol 000005: blood component fate information. Field 8: wasted classification code
Table A1.1Serological, virological and other preparations
Table A1.2Coagulation preparations: WHO International Standards
Table A1.3Coagulation preparations: British Standards
Table A2.1Mapping from characters to ISO 7064 check values
Table A2.2Example of displayed numbers